CLASS III Drug recall · Reported 15 Jun 2022 · FDA Enforcement Report

Alprostadil Injection USP 500 mcg/mL Single Dose Vial, 5 vials recalled

Teva Pharmaceuticals USA is recalling Alprostadil Injection USP 500 mcg/mL Single Dose Vial, 5 vials per, distributed nationwide in the US. The recall was initiated on 18 May 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #:100022404, Exp Date 10/2022; Lot #:100023333, Exp Dat 12/2022
Quantity recalled3109 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0988-2022
FDA event ID
90239
Recalling firm
Teva Pharmaceuticals USA, Parsippany, NJ
Classification
Class III
Status
Terminated
Recall initiated
18 May 2022
FDA classified
7 Jun 2022
Reported
15 Jun 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

18 May 2022Recall initiated by company
7 Jun 2022Classified by FDA+20 days
15 Jun 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Alprostadil Injection USP 500 mcg/mL, 1 mL Single Dose Vial, 5 vials per Carton, Rx Only, Carton NDC 0703-1501-02, Distributed by: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, Vial NDC 0703-1501-01

Where it was distributed

Product was distributed nationwide in the US Market

Nationwide

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing

Which lots are affected?

Lot #:100022404, Exp Date 10/2022; Lot #:100023333, Exp Dat 12/2022

Where was it sold?

Product was distributed nationwide in the US Market

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Teva Pharmaceuticals USA

All 280

Other Alprostadil recalls

All 41